Duosheng Luo

814 total citations
28 papers, 593 citations indexed

About

Duosheng Luo is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Duosheng Luo has authored 28 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Pharmacology. Recurrent topics in Duosheng Luo's work include Gut microbiota and health (6 papers), Ginseng Biological Effects and Applications (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Duosheng Luo is often cited by papers focused on Gut microbiota and health (6 papers), Ginseng Biological Effects and Applications (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Duosheng Luo collaborates with scholars based in China, Macao and Bangladesh. Duosheng Luo's co-authors include Xianglu Rong, Jiao Guo, Jiao Guo, Kechun Chen, Weijian Bei, Laiyou Wang, Xing Chang, Xiuteng Zhou, Peizheng Yan and Tian Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Journal of Hepatology.

In The Last Decade

Duosheng Luo

26 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duosheng Luo China 13 339 161 90 80 61 28 593
Chengmu Hu China 18 387 1.1× 201 1.2× 62 0.7× 117 1.5× 69 1.1× 33 848
Dongyan Gao China 15 368 1.1× 212 1.3× 72 0.8× 115 1.4× 67 1.1× 21 771
Tian Zhang China 16 391 1.2× 233 1.4× 132 1.5× 75 0.9× 46 0.8× 40 826
Lin-Lin Kang China 7 386 1.1× 171 1.1× 79 0.9× 53 0.7× 141 2.3× 7 723
Yanqi Dang China 20 494 1.5× 249 1.5× 114 1.3× 69 0.9× 114 1.9× 41 878
Yong Su China 15 365 1.1× 91 0.6× 59 0.7× 102 1.3× 46 0.8× 36 665
Zhishen Xie China 17 439 1.3× 116 0.7× 97 1.1× 98 1.2× 54 0.9× 54 850
Dingzhu Shen China 16 302 0.9× 122 0.8× 123 1.4× 33 0.4× 56 0.9× 32 722
Wen Shan China 10 229 0.7× 205 1.3× 89 1.0× 50 0.6× 63 1.0× 13 508
Fengying Guan China 13 274 0.8× 132 0.8× 101 1.1× 105 1.3× 60 1.0× 21 564

Countries citing papers authored by Duosheng Luo

Since Specialization
Citations

This map shows the geographic impact of Duosheng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duosheng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duosheng Luo more than expected).

Fields of papers citing papers by Duosheng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duosheng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duosheng Luo. The network helps show where Duosheng Luo may publish in the future.

Co-authorship network of co-authors of Duosheng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Duosheng Luo. A scholar is included among the top collaborators of Duosheng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duosheng Luo. Duosheng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Zhen, et al.. (2025). Recent advances in the crosstalk between bone and vascular system: from mechanism to therapy. Cellular Signalling. 135. 112001–112001.
2.
Yang, Ling, Tianxin Zhu, Xin Wang, et al.. (2024). Aucubin ameliorates atherosclerosis by modulating tryptophan metabolism and inhibiting endothelial-mesenchymal transitions via gut microbiota regulation. Phytomedicine. 135. 156122–156122. 9 indexed citations
3.
Wang, Xin, et al.. (2024). Exploring tryptophan metabolism: The transition from disturbed balance to diagnostic and therapeutic potential in metabolic diseases. Biochemical Pharmacology. 230(Pt 1). 116554–116554. 14 indexed citations
4.
Zhu, Tianxin, et al.. (2024). SphK1 deficiency ameliorates the development of atherosclerosis by inhibiting the S1P/S1PR3/Rhoa/ROCK pathway. Cellular Signalling. 121. 111252–111252. 4 indexed citations
5.
Shao, Xiaoqi, Wenru Zeng, Qing Wang, et al.. (2024). Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaques. Journal of Ethnopharmacology. 324. 117705–117705. 4 indexed citations
6.
Liu, Yuqing, et al.. (2024). Hydroxysafflor yellow A, a natural food pigment, ameliorates atherosclerosis in ApoE −/− mice by inhibiting the SphK1 / S1P / S1PR3 pathway. Food Science & Nutrition. 12(11). 8939–8955. 2 indexed citations
7.
Zhu, Tianxin, et al.. (2024). Combining metabolomics and 16S rRNA sequencing to investigate the effects of fecal microbiota transplantation intervention in aging mice. SHILAP Revista de lepidopterología. 5(1). 33–44. 2 indexed citations
8.
Zhang, Yue, Hongtao Diao, Dongwei Wang, et al.. (2023). Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA. Journal of Ethnopharmacology. 317. 116766–116766. 12 indexed citations
9.
Xu, Xuefeng, et al.. (2023). The role of SphK/S1P/S1PR signaling pathway in bone metabolism. Biomedicine & Pharmacotherapy. 169. 115838–115838. 10 indexed citations
10.
Luo, Duosheng, et al.. (2022). Tianhuang formula reduces the oxidative stress response of NAFLD by regulating the gut microbiome in mice. Frontiers in Microbiology. 13. 984019–984019. 22 indexed citations
11.
Chang, Xing, et al.. (2021). Quercetin Improves Cardiomyocyte Vulnerability to Hypoxia by Regulating SIRT1/TMBIM6‐Related Mitophagy and Endoplasmic Reticulum Stress. Oxidative Medicine and Cellular Longevity. 2021(1). 5529913–5529913. 92 indexed citations
12.
Lan, Tian, Yufeng Hu, Fengjiao Hu, et al.. (2021). Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling. Journal of Hepatology. 76(2). 407–419. 49 indexed citations
13.
Luo, Duosheng, et al.. (2019). Untargeted Metabolomics Reveals the Protective Effect of Fufang Zhenshu Tiaozhi (FTZ) on Aging-Induced Osteoporosis in Mice. Frontiers in Pharmacology. 9. 1483–1483. 28 indexed citations
14.
15.
Liu, Qianqian, Lan Yu, Meili Lü, et al.. (2017). Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice. Journal of Vascular Research. 54(3). 123–130. 29 indexed citations
16.
Luo, Duosheng, Kunping Li, Xianglu Rong, & Jiao Guo. (2016). Study on the compatibility rule of tianhuang fang in treating hyperlipidemia based on urine metabonomics. 32(4). 88. 2 indexed citations
17.
Wang, Laiyou, et al.. (2014). Potential synergistic effects of Chinese herbal prescription FTZ components detected in blood towards hepatic lipid-modulating targets. Complementary Therapies in Medicine. 22(5). 887–893. 12 indexed citations
18.
Cao, Yang, Weijian Bei, Yinming Hu, et al.. (2012). Hypocholesterolemia of Rhizoma Coptidis alkaloids is related to the bile acid by up-regulated CYP7A1 in hyperlipidemic rats. Phytomedicine. 19(8-9). 686–692. 53 indexed citations
19.
Tang, Futian, Jiao Guo, Wei He, et al.. (2011). Effects of Fufang Zhenzhu Tiaozhi Prescription (复方贞术调脂方), A Chinese herbal preparation, on atherosclerosis in ApoE-/- mice and related mechanisms. Chinese Journal of Integrative Medicine. 14 indexed citations
20.
Luo, Duosheng. (2010). Progress on Blood Lipid-regulating Active Ingredients from Traditional Chinese Medicine. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengmu Hu Breakdown of academic impact, for papers by Dongyan Gao Breakdown of academic impact, for papers by Tian Zhang Breakdown of academic impact, for papers by Lin-Lin Kang Breakdown of academic impact, for papers by Yanqi Dang Breakdown of academic impact, for papers by Yong Su Breakdown of academic impact, for papers by Zhishen Xie Breakdown of academic impact, for papers by Dingzhu Shen Breakdown of academic impact, for papers by Wen Shan Breakdown of academic impact, for papers by Fengying Guan
Rankless by CCL
2026